- ►ersj.org.uk MR Sears, A Ottosson, F Radner, S Suissa - European Respiratory Journal, 2009 - Eur Respiratory Soc There were eight asthma-related deaths (0.34 per 1,000 person-yrs) among 49,906
formoterol-randomised patients (92% using ICS), and two (0.22 per 1,000
person-yrs) among 18,098 patients (83% using ICS) not randomised to ... Cited by 15 - Related articles - All 6 versions
- ►googlepages.com [PDF] M Kraft - New England Journal of Medicine - content.nejm.org You are consulted by a 30-year-old white woman, who holds an administrative
position in an office and has a lifelong history of asthma, about the treatment
of her condition. In childhood, the patient visited her local hospital for ... Cited by 11 - Related articles - BL Direct - All 8 versions
SJ Edwards, K Gruffydd-Jones, DP Ryan - Current Medical Research and Opinion®, 2007 - informahealthcare.com Objective: To compare the effectiveness of budesonide/formoterol using fixed
dosing (BUD/FORM) with inhaled corticosteroid (ICS) alone or alternative ICS and
long-acting ß2-agonist (LABA) regimens for adults with moderate/severe ... Cited by 8 - Related articles - BL Direct - All 3 versions
R Buhl, C Vogelmeier - Current Medical Research and Opinion®, 2007 - informahealthcare.com Background: An inhaled corticosteroid (ICS) or an ICS/ long-acting ß2-agonist
(LABA) combination plus short- acting ß2-agonist (SABA) as needed for symptom
relief is recommended for persistent asthma. Additionally, ... Cited by 8 - Related articles - BL Direct - All 4 versions
- ►currentopinion.com J Oppenheimer, HS Nelson - Current Opinion in Pulmonary Medicine, 2008 - journals.lww.com Introduction Safety concerns regarding the use of long-acting b-2 agonists
(LABAs) have been voiced since soon after their availability. In a letter to the
editor of the New England Journal of Medicine, Finkelstein described two ... Cited by 7 - Related articles - BL Direct - All 5 versions
LE Mansfield - Allergy and Asthma Proceedings, 2008 - ingentaconnect.com ABSTRACT The combination of long-acting beta-agonist (LABA) bronchodilators with
inhaled corticosteroids (ICSs) has been shown to be an extremely effective
treatment for asthma. Use of LABA as monotherapy for asthma is associated ... Cited by 6 - Related articles - BL Direct - All 2 versions
RMM Geijer, W Van Hensbergen, B Bottema … - Huisarts Wet, 2001 - nascholing.net Inleiding De NHG-Standaard Astma bij volwassenen geeft richtlijnen voor de
diagnostiek en behandeling van astma of bij het vermoeden van astma bij personen
vanaf 16 jaar.1 Richt- lijnen voor de diagnostiek of behandeling van astma ... Cited by 4 - Related articles - View as HTML - All 5 versions
MS Balter, AD Bell, AG Kaplan, H Kim, A … - Canadian Medical Association Journal, 2009 - Can Med Assoc Sara is a 41-year-old secretary in an autobody shop who comes to see you for
evaluation of intermittent episodes of wheezing and shortness of breath that
have progressed over the past 2 years. She feels that she has more ... Cited by 2 - Related articles - All 3 versions
RA McIvor, KR Chapman - The Lancet, 2008 - Elsevier The first international asthma guidelines meeting was held in Toronto almost 20
years ago and the consensus conclusions from this meeting were published the
following year. 1 Since then, many national and international groups have ... Cited by 2 - Related articles - All 11 versions
MT Wang, GH Skrepnek, E Armstrong, DL … - Current Medical Research and Opinion®, 2008 - informahealthcare.com Rationale: Studies evaluating the safety of salmeterol are inconclusive, which
might be the result from not taking into account the impact of concomitant
inhaled corti costeroids (ICS). Objective: To study whether salmeterol use ... Cited by 2 - Related articles - BL Direct - All 6 versions
